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the concept of endovascular aneurysm repair (EVAR). They are
designed to improve the proximal seal in short infrarenal necks and
to make endovascular repair possible in patients with juxta- and
suprarenal aneurysms. Until now, the complex anatomy of the
suprarenal segment of the abdominal aorta has required patient-
speciﬁc custom endograft manufacturing. In the acute and urgent
setting, the off-the-shelf branched device is the Holy Grail to over-
come the associated waiting time of these custom-made devices.
Dr Kitagawa and colleagues describe their initial experience
with the Zenith p-branch standard fenestrated endovascular graft
for the treatment of juxtarenal abdominal aortic aneurysms in 16
(predominantly elective) patients. They describe a 100% technical
success rate and minimal problems during short-term follow-up.
Although these are promising results, the limitations of the article
are also obvious. The study describes a highly selected group of
patients, treated in a high-volume center of excellence and almost
complete absence of follow-up (0, 1-12 months).It is tempting to extrapolate the encouraging long-term results of
the custom-made Zenith fenestrated device, but it must be realized
that this off-the-shelf version is not just a version of the Food and
DrugAdministration-approved fenestrateddevicewith cleverly chosen
geometry. The pivoting renal fenestration is a new design, which is, at
least in theory, one step away from the concept of self-sealing fenestra-
tions. Although the instructions for use in Table I seem to require
a 4-mm seal around all fenestrations, the authors have used the device
in patients with a 4-mm seal distal to the superiormesenteric artery. As
such, the Zenith p-branch system seems to be suggested for pararenal
aneurysms in which, consequently, the renal stent grafts act as endo-
graft branches. The durability of this pivot-fenestration seal, however,
is completely unproven and questionable at best.
What will be the impact of this off-the-shelf fenestrated
device? Although the authors optimistically seem to suggest that
72% of juxtarenal aneurysms could be treated with the p-branch
device, careful reading indicates that this percentage comes from
a retrospective study of 288 patients treated in the Cleveland
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was considered suitable for custom-made (elective) fenestrated
EVAR and that had at least a 4-mm seal below the superior mesen-
teric artery. Unfortunately, in this prospective study, the authors
did not record the suitability for this device on an all-comers basis,
during the inclusion period. That data could have validated the
retrospective study on which the geometry of the design has
been based apparently. It is understood that this center was
involved in other premarket studies on fenestrated and branched
devices, but now we are left with nothing more than an estimation
of the applicability. If in this high-volume center of excellence,
yearly, only approximately 20 elective patients are considered suit-
able, it is hard to imagine that this off-the-shelf-device, when
stocked in an average EVAR center, would be used more than
once or twice per year for urgent and emergent juxtarenalaneurysms. The elective patients would be better off waiting for
a custom-made device of proven durability.
Even though this is a small series of highly selected cases
without evidence of long-term durability, it does mark the begin-
ning of an era in which more and more patients with short necks
and juxtarenal aneurysms will be amenable for endovascular repair
using stocked endografts. Several companies are now running
pre-market studies of devices that allow for off-the-shelf treatment
of juxtarenal aneurysms. This evolution will deﬁnitely further
reduce the percentage of patients who are currently declined
for endovascular repair based on inadequate proximal seal or
who are required to wait a long time for a custom-made device.
Last but not least, endovascular treatment of symptomatic or
ruptured juxtarenal aneurysms will become available for many
patients; not there yet, but an important step forward.
